IPVS Online Debate: Targets for detection and management of HPV associated disease: strengths, limitations, and future research

IPVS Online Debate: Targets for detection and management of HPV associated disease: strengths, limitations, and future research

Wednesday, 15 April 2026
16:00 CET (Geneva) / 10:00 EST (New York)

Topic:

Participate in this free debate-style webinar and join leading experts for an engaging online debate on targets for the detection and management of HPV-associated disease. This session will examine the role of HPV DNA and mRNA assays across the screening pathway, including primary screening, triage, and test of cure. Speakers will discuss the strengths and limitations of current HPV detection approaches, compare DNA-based and mRNA tests in terms of sensitivity, specificity, and clinical implications, and explore how to choose the most appropriate test for screening programs. The webinar will also highlight recent advances in basic science and the key challenges in translating these discoveries into clinical practice.

WEBINAR AIMS

1) Describe the role of HPV mRNA assays and DNA testing within the screening workflow (primary screening, triage, test of cure).
2) Explain the strengths and limitations of current approaches for HPV detection.
3) Discuss how to choose the most appropriate test for a screening program, comparing DNA-based and mRNA assays in terms of sensitivity, specificity, and clinical implications.
4) Summarize and discuss advances in basic science for HPV detection and key hurdles to translating these findings into clinical practice.

This webinar will be recorded. If you have missed the previous IPVS webinars, you can watch the videos on demand on the IPVS members’ website.